跳至主要内容
临床试验/CTRI/2025/09/094513
CTRI/2025/09/094513尚未招募2/3 期

Randomised Controlled Study of Jyotishmatyadi Churna in The Management of Artava Kshaya with Special Reference to Oligomenorrhea.

Dr. Pooja Suradkar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年9月21日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Study aims to compare the effects of Jyotishmatyadi churna and shatapushpadi churna in managing artav kshaya,focusing on internal applications.

研究概览

简要总结

Artava Kshaya, described in Ayurveda under Yonivyapad and Artava Vikara, presents as irregular, scanty, or painful menstruation and is correlated with oligomenorrhea and scanty menses in modern science. Conventional allopathic management relies on hormonal therapy with temporary effects and adverse reactions. Ayurveda emphasizes root-cause management using Agneya dravyas that enhance Rasa and Rakta Dhatu, balancing Vata-Pitta. Jyotishmatyadi Churna, with uterine restorative and Artavajanana properties, is selected as a safe, cost-effective, and holistic option for managing Artava Kshaya.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • Married/unmarried patients suffering from any two of the following cardinal symptoms of Artavakshaya: a. If the interval between 2 menstrual cycles exceeds more than 35 days. b. Yoni Vedana.
  • Pain during menstruation in internal genital organs.

排除标准

  • a.Breastfeeding within the past 3 months.
  • b.History of intake of oral contraceptive or ovulation inducing agent within the past 3 months.
  • 3.Established endocrine disorders.
  • 4.Interval between 2 consecutive menstrual cycles is more than 6 months.
  • 5.Oligomenorrhea with hypermenorrhoea.
  • 6.Patient suffering from any uterine or pelvic pathology.
  • 7.Patient with any malignancy or anatomical defect.
  • 8.Patient suffering from any severe systemic disorders.
  • 9.Intake of psychoactive drugs or antiepileptic drugs (valproic acid).

结局指标

主要结局

Study aims to compare the effects of Jyotishmatyadi churna and shatapushpadi churna in managing artav kshaya,focusing on internal applications.

时间窗: 3 months

The primary outcome focuses on the clinical efficacy of Jyotishmatyadi churna vs shatapushpadi churna in managing aartav kshaya. It will be assessed based on sysmtomatic relief (pain)and objective parameters (Artavpraman).Assesments will occur at baseline , during treatment ,post treatment and follow ups.

时间窗: 3 months

次要结局

  • Study aims to compare the effects of Jyotishmatyadi churna and shatapushpadi churna in managing artav kshaya,focusing on internal applications.(1. Detailed analysis of guna,karma of Jyotishmatyadi churna and shatapushpadi churna.)

研究者

发起方
Dr. Pooja Suradkar
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Pooja Suradkar

L.K.R.Ayurvedic Mahavidyalay PG Training and Research center , Gadhinglaj.

研究点 (1)

Loading locations...

相似试验